The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
In 2020, Ryan Lu led a study demonstrating that expression of three Yamanaka factors - Oct4, Sox2, and Klf4 (OSK) - could restore youthful DNA methylation patterns in retinal ganglion cells, promote optic nerve regeneration, and restore vision in aged mice and mouse models of glaucoma (Lu et al., Nature, 2020).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.